The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo.
Ingargiola
G B
GB
Institute of Urology, University of Palermo, Italy.
Lamartina
M
M
Cassata
G
G
Corselli
G
G
Serretta
V
V
Caramia
G
G
Rizzo
F P
FP
Pavone-Maculuso
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011300:Preoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
D002945:Cisplatin; D008727:Methotrexate